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Hirschsprung Disease (HSCR) is a potentially deadly birth defect characterized by the absence of the
enteric nervous system (ENS) in distal bowel. Although HSCR has clear genetic causes, no HSCR-asso-
ciated mutation is 100% penetrant, suggesting gene–gene and gene-environment interactions determine
HSCR occurrence. To test the hypothesis that certain medicines might alter HSCR risk we treated zeb-
raﬁsh with medications commonly used during early human pregnancy and discovered that ibuprofen
caused HSCR-like absence of enteric neurons in distal bowel. Using fetal CF-1 mouse gut slice cultures,
we found that ibuprofen treated enteric neural crest-derived cells (ENCDC) had reduced migration, fewer
lamellipodia and lower levels of active RAC1/CDC42. Additionally, inhibiting ROCK, a RHOA effector and
known RAC1 antagonist, reversed ibuprofen effects on migrating mouse ENCDC in culture. Ibuprofen also
inhibited colonization of Retþ/ mouse bowel by ENCDC in vivo and dramatically reduced bowel co-
lonization by chick ENCDC in culture. Interestingly, ibuprofen did not affect ENCDC migration until after
at least three hours of exposure. Furthermore, mice deﬁcient in Ptgs1 (COX 1) and Ptgs2 (COX 2) had
normal bowel colonization by ENCDC and normal ENCDC migration in vitro suggesting COX-independent
effects. Consistent with selective and strain speciﬁc effects on ENCDC, ibuprofen did not affect migration
of gut mesenchymal cells, NIH3T3, or WT C57BL/6 ENCDC, and did not affect dorsal root ganglion cell
precursor migration in zebraﬁsh. Thus, ibuprofen inhibits ENCDC migration in vitro and bowel coloni-
zation by ENCDC in vivo in zebraﬁsh, mouse and chick, but there are cell type and strain speciﬁc re-
sponses. These data raise concern that ibuprofen may increase Hirschsprung disease risk in some ge-
netically susceptible children.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The enteric nervous system (ENS) is an intrinsic neuronal and
glial network in the bowel that controls intestinal function (Fur-
ness, 2012; Sasselli et al., 2012). Most ENCDC that give rise to the
ENS begin to delaminate from vagal neural tube by E8.5 in mice
and prior to week four in humans (Fu et al., 2004; Kapur et al.,
1992). Sacral ENCDC also contribute to distal bowel ENS (Kapur,iladelphia Research Institute
sylvania Abramson Research
hia, PA 19104-4318, USA.
. Heuckeroth).2000; Wang et al., 2011). Vagal ENCDC migrate to the foregut and
then begin coordinated proliferation, rostro-caudal migration, and
differentiation, a process that normally results in interconnected
neurons and glia throughout the bowel by E13.5 in mice and by
week 7 in humans. This migratory route is one of the longest
traversed by any cell during development. In one in 5000 human
infants, ENCDC do not colonize the bowel completely, causing
Hirschsprung disease (HSCR), a condition deﬁned by the absence
of distal bowel enteric neurons (Heuckeroth, 2013; Hirschsprung,
1888; McKeown et al., 2013; Skinner, 1996).
HSCR is potentially fatal because aganglionic bowel (i.e., bowel
without neurons) tonically contracts, causing constipation, bilious
vomiting, abdominal distension, enterocolitis, and sepsis (Dasgupta
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with HSCR (80%) have only a short region of aganglionic bowel
(Amiel et al., 2008; Suita et al., 2005) and even modestly increased
ENCDC bowel colonization (e.g. 5–10% increase) might have pre-
vented HSCR. For children with extensive aganglionosis, having only
slightly greater bowel colonization by ENCDC could prevent the
need for intravenous nutrition and associated life-threatening in-
fections. Therefore, it is valuable to identify non-genetic potentially
avoidable factors that inﬂuence ENCDC migration.
Because ENS development depends on many signaling path-
ways (Anderson et al., 2006; Goldstein et al., 2013; Lake and
Heuckeroth, 2013; Laranjeira and Pachnis, 2009), many medi-
cines may increase HSCR risk. One critical pathway includes RET
receptor tyrosine kinase (Pachnis et al., 1993; Schuchardt et al.,
1994), the ligand glial cell line-derived neurotrophic factor
(GDNF), the co-receptor GFRα1 (Airaksinen and Saarma, 2002)
and the small RhoGTPases RAC1 and CDC42 that induce actin
polymerization and reorganization at the leading edge of mi-
grating cells (de Curtis, 2008; Fukata et al., 2003; Goto et al.,
2013; Ridley, 2006; Stewart et al., 2007; Vohra et al., 2007a).
Among other roles, RAC1 induces lamellipodia, promotes ENCDC
migration in vitro and ex vivo and inhibits RHOA, a small GTPase
(Stewart et al., 2007; Wu et al., 2009). RHOA also inhibits RAC1
via its effector ROCK (Guilluy et al., 2011; Nakayama et al., 2008).
The complex signaling pathways needed for normal develop-
ment increase the vulnerability of ENS precursors to medicinesTable 1
Medicines tested for an effect on zebraﬁsh ENS development.
Medicine Human therapeutic blood con-
centration (μM)
Lowest concentration that af
ENCDCa (μM)
Acetaminophen 65–130 2315
Acetylsalicylic Acid 110–1700 333
Caffeine 10–50 257
Chlorpheniramine 0.013–0.025 256b
Clomiphene 0.050c 83b
Dextromethorphan 0.74–1.3 368
Diphenhydramine 0.034–0.34 103b
Doxylamine 0.3c 1287b
Erythromycin 0.68–3.4 41363
Guaifenesin 7.6c 43531
Ibuprofen 25–240 25
Loratadine 0.13c 41306
Sulfamethoxazole 200–790 1974
Ibuprofen and acetylsalicylic acid inhibit bowel colonization by ENCDC in zebraﬁsh at d
a Data in this column indicate the lowest drug concentration that causes a statisti
(compared to 1% DMSO vehicle) after treatment with drug from 34–96 hpf.
b Indicates medicines that caused severe malformation or death at concentrations l
c Based on the available literature we indicate peak human therapeutic blood concethat impact these and many other signaling pathways.
By testing medicines commonly used during early human
pregnancy, we discovered that ibuprofen dramatically reduced
bowel colonization by ENCDC in zebraﬁsh and chick. Furthermore,
ibuprofen delayed Retþ / mouse bowel colonization by ENCDC
in vivo, but effects were not observed in WT mice. Consistent with
these observations, ibuprofen reduced migration speed on 2-di-
mensional surfaces, reduced lamellipodia and reduced ﬁlamentous
actin in murine ENCDC. These changes correlated with reduced
active RAC1/CDC42. Furthermore, ibuprofen's effects on migration
could be prevented using a ROCK inhibitor. In contrast, ibuprofen
did not slow migration or reduce lamellipodia in mouse gut me-
senchymal or NIH3T3 cells. Surprisingly, mice with mutations in
Ptgs (i.e., cyclooxygenase, COX), ibuprofen's main therapeutic tar-
get, had normal ENCDC bowel colonization and normal migration
in vitro. Additionally, live imaging experiments demonstrated that
ENCDC required at least three hours of exposure to ibuprofen
before ENCDC migration speed was impacted, a much slower time
course than would be expected for a solely COX dependent effect.
Collectively these studies suggest ibuprofen use during early
pregnancy could increase HSCR risk in some genetically suscep-
tible children. This may be important since 23.5% of women in the
United State take ibuprofen during early pregnancy (Thorpe et al.,
2013).fects Concentration range tested (μM) Reference
[Actual concentrations tested (number eval-
uated at each concentration)]
331–3308 Ritschel and Kerns (2009)
[331 (9), 662 (8), 1650 (8), 2315 (7) 3308
(7)]
56–666 Ritschel and Kerns (2009)
[56 (21), 111(22), 222 (22), 333 (24), 666
(7)]
5–1030 Baselt (1982)
[5 (21), 51 (15), 257 (17), 514 (18), 1030
(16)]
13–1279 Ritschel and Kerns (2009)
[13 (6), 26 (9), 128 (10), 256 (5), 1279 (6)]
17–836 Ghobadi et al. (2009)
[17 (9) 83 (Z5), 167 (Z5) 836 (Z5)]
18–1840 Ritschel and Kerns (2009)
[18 (9), 37 (9) 184 (7) 368 (7), 1840 (Z5)]
17–343 Ritschel and Kerns (2009)
[17 (9) 34 (9) 103 (Z5), 172 (Z5), 343
(Z5)]
129–1287 Ritschel and Kerns (2009)
[129 (8), 257 (8) 1287 (6)]
14–1363 Ritschel and Kerns (2009)
[14 (7), 68 (9), 136 (9), 681 (8), 1363 (9)]
252–3531 Aluri and Stavchansky
(1993)[252 (5), 504 (9), 1009 (9), 2522 (7), 3531
(8)]
2.5–50 Ritschel and Kerns (2009)
[2.5 (21) 5 (24), 12.5 (24), 25 (24), 50 (20)]
65–1306 Hilbert et al. (1988)
[65 (12), 131 (12), 261 (9) 652 (9) 1306 (10)]
400–7896 Ritschel and Kerns (2009)
[395 (10), 987 (11), 1974 (12), 3948 (11),
7896 (8)]
oses within the human therapeutic range.
cally signiﬁcant increase in the length of distal zebraﬁsh bowel that lacks ENCDC
isted (i.e., defects were not ENS selective).
ntration instead of therapeutic blood ranges.
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2.1. Zebraﬁsh
Wild type AB zebraﬁsh, fertilized in vitro, were exposed to
drugs from 34 to 96 hpf (hours post fertilization) in E3 media with
1% DMSO (Murphey and Zon, 2006). At 96 hpf, zebraﬁsh were
stained with HuC/D antibody to visualize neurons. Uncolonized
gut was measured from most distal HuC/Dþ cell to end of bowel.
Drugs (from Sigma, St. Louis) tested, number of ﬁsh evaluated and
drug concentrations are in Table 1.
2.2. Avian intestine organ culture
Fertilized White Leghorn chicken eggs from commercial bree-
ders were maintained in a 37 °C humidiﬁed incubator. E6 midgut
plus hindgut from umbilicus to cloaca was pinned to Sylgard,
cultured in DMEM, 100 U/mL penicillin-G, 0.1 mg/mL streptomycin
(Sigma), DMSO (5 μM), þ/ ibuprofen (250 μM) for 48 h and then
processed for immunocytochemistry. 5-Ethynyl-2' deoxyuridine
(EdU) (10 μM, Invitrogen) was added 3 h before ﬁxation.
2.3. Mice
Mice used include WT CF-1 (Charles River Laboratories), WT
C57BL/6J (The Jackson Laboratory), Ptgs1tm1Unc (called Ptgs1 or
Cox1, RRID:MGI_4366280), Ptgs2tm1Unc (called Ptgs2 or Cox2, RRID:
MGI_4366244) (C57BL/6J background) (Langenbach et al., 1995;
Morham et al., 1995), Sox10tm1Weg (called Sox10þ / or Sox10 LacZ,
RRID:MGI_4437131) (C3H background) (Britsch et al., 2001) (from
M. Wegner (Friedrich Alexander University Erlangen Nuremberg,
Erlangen, Germany) and M. Southard-Smith (Vanderbilt Uni-
versity, Nashville, Tennessee, USA)), and Rettm1Jmi (Ret (tau-EGFP-
myc), Ret-TGM, RRID:MGI_3623107, called Retþ /), C57BL/6J
background (Enomoto et al., 2001). The day of the vaginal plug
was called E0.5. Mice were genotyped by PCR as described in the
references above.
2.4. Midgut slice explant culture
E12.5 small bowel (midgut) was cut into 300–500 μm slices.
These slices were cultured on ﬁbronectin-coated (250 μg/mL; Life
Technologies) plastic or glass Lab-Tek Permanox chamber slides
(ThermoFisher) in OptiMem (Life Technologies), 2 mM L-glutamine
(Life Technologies), 100 IU/mL penicillin, 100 μg/mL streptomycin
(Life Technologies). Ibuprofen stock (1 g/L) was prepared fresh in
media daily. Unless noted, ibuprofen was added when slices were
plated. Four hours after plating, GDNF (100 ng/mL ﬁnal con-
centration) was added to cultures, which were then maintained
for an additional 16 h (37 °C, 5% CO2) after GDNF addition. When
needed, 10 μM bromodeoxyuridine (BrdU) was added four hours
before ﬁxation. Y-27632 (5 μM, Sigma, St. Louis MO) in DMSO was
added four hours after plating slices. 16, 16-dimethyl prostaglandin
E2 and 16, 16-dimethyl prostaglandin F2 (Cayman Chemicals, Ann
Arbor, MI) dissolved in ethanol were added (ﬁnal concentration
1 μM) at the same time as GDNF (for 16, 16-dimethyl pros-
taglandin E2) or at plating (for 16, 16-dimethyl prostaglandin F2).
Control cultures received equivalent diluent volumes.
2.5. Immunoselected ENCDC culture
E12.5 CF-1 small and large bowel were treated with collagenase
(0.2 mg/mL) and dispase (0.2 mg/mL) for 15 min at 37°C, tritu-
rated, resuspended in media (Neurobasals (Life Technologies),
B27s (50x, Life Technologies), 2 mM L-glutamine, 100 IU/mL pe-
nicillin, 100 μg/mL streptomycin), and then exposed to rabbit anti-p75NTR (anti-nerve growth factor receptor, P75, EMD Millipore,
1:1000, one hour, 4 °C), followed by goat anti-rabbit coupled
paramagnetic beads (anti-rabbit IgG MicroBeads1:50, Miltenyi
Biotec, GmbH) (30 min, 4 °C). ENCDC (p75NTR positive) were
isolated with MACS columns (Miltenyi Biotec, GmbH), before cul-
turing on poly-D-lysine (100 μg/mL, Sigma, St. Louis) and laminin
(20 μg/mL, BD Biosciences) coated glass chamber slides (Sato and
Heuckeroth, 2008). Cells were treated with GDNF (50 ng/mL) with
or without ibuprofen (250 μM) at plating and then grown 48 h
before ﬁxation.
2.6. In vivo mouse ibuprofen treatment
Pregnant mice were fed Lab Diet 5053 (Test Diet, Richmond, IN)
with or without 375 ppm ibuprofen from E8.5 until analysis.
2.7. Embryo sections
10 μM sagittal E12.5 CF-1 mouse sections were prepared from
immersion ﬁxed (4% paraformaldehyde overnight, rotating, 4 °C),
sucrose treated (30% overnight), frozen (Optimal Cutting Tem-
perature Compound, Tissue-Tek) mice.
2.8. Immunohistochemistry
Fixed zebraﬁsh (2% paraformaldehyde, two hours, 25 °C) were
washed in PBS, stained with mouse anti-HuC/HuD (16A11) anti-
body (overnight, 4 °C) and examined after Alexa Fluors anti-
mouse 594 secondary (1:250, Life Technologies) (two hours, 25 °C)
treatment.
Mouse cells were ﬁxed (4% paraformaldehyde, 25 °C) for
20 min (slice and dissociated culture) or 30 min (whole bowel),
washed (PBS or Tris-buffered saline plus 0.1% Triton-X (TBST)), and
blocked (4% normal donkey serum/TBST, 1 h, 25 °C or overnight
4 °C) before primary antibodies (Table 2) were applied in TBST
(4 °C, overnight). TuJ1 and Phalloidin were applied only two hours
at 25 °C. Samples were washed in PBS or TBST before incubating
with secondary antibodies (Alexa Fluors Donkey anti-Rabbit,
Donkey anti-goat, Donkey anti-mouse 488, 594, or 647 nm, In-
vitrogen, 1:400) and DAPI (100 ng/mL, 4′,6-diamidine-2-phenyli-
dole-dihydrochloride, Vector Labs) in TBST (1 h, 25 °C) and then
washing again in PBS or TBST before mounting (50% glycerol).
Avian bowel was ﬁxed (4% paraformaldehyde in PBS, 1 h),
rinsed (PBS), incubated in 15% sucrose/PBS (overnight, 4 °C), then
in 7.5% gelatin, 15% sucrose/PBS (37 °C, 1 h), before freezing
(50 °C, 2-Methylbutane, Sigma). 10 μm frozen sections on Probe
On Plus slides (Fisher Scientiﬁc) were stained with ENCDC speciﬁc
anti-chicken N-cadherin antibody (Nagy et al., 2012) Nuclei were
DAPI stained. EdU was detected using Clik-iT EdU Imaging Kit
(Invitrogen).
2.9. Active RAC1/CDC42 and RHOA measurements
NIH3T3 (ATCC) for scratch test were grown on glass 8-well
chamber slides to 100% conﬂuence in DMEM (high glucose), 10%
fetal calf serum (FCS), 100 IU/mL penicillin, and 100 μg/mL strep-
tomycin. 250 μM ibuprofen was added two hours before scratching
to remove some cells using a 10 μL pipette tip. Media was changed
after the scratch. For RAC1/CDC42 and RHOA studies, NIH3T3 were
starved (18 h in 1% FCS, then 24 h in 0% FCS), then stimulated with
100 ng/mL RAC1/CDC42 Activator II (3 min, Cytoskeleton, Denver)
or 100 μg/mL Rho Activator I (30 min, Cytoskeleton, Denver). During
stimulation, RAC1/CDC42 control cells were kept in 0% FCS media
while RHOA control cells were in 1% FCS media.
After culture ENCDC and NIH3T3 were ﬁxed (4% paraf-
ormaldehyde, 20 min, 25 °C), permeabilized in TBST (55 °C, one
Table 2
Primary and secondary antibodies for immunohistochemistry or immunoselection.
Antibody Concentration Catalog # Source
Rabbit anti-Tuj1 1:10,000 PRB-435P Covancea; RRID:AB_10063850
Goat anti-RET 1:100 GT15002 Neuromics; RRID:AB_2179886
Mouse anti-BRDU (Conjugated to Alexa-594) 1:100 A21304 Invitrogen; RRID:AB_221472
Rabbit anti-cleaved caspase-3 1:100 9661 Cell Signaling Technology; RRID:AB_2314091
RRID:AB_2314091
Mouse anti-PPARγ 1:100 sc-7273 Santa Cruz; RRID:AB_628115
Phalloidin (Conjugated to Alexa-488) 1:50 A12379 Invitrogen; RRID:AB_2315147
Rabbit anti-GST 1:100 sc-35614 Santa Cruz; RRID:AB_647587
Mouse anti-HuC/HuD (Biotin Conjugate (16A11)) 1:800 A21272 Invitrogen; RRID:AB_10375876
Mouse anti-chicken N-cadherin antibody (clone 6B3) 1:5 6B3 Developmental Studies Hybridoma Bank, Iowa; RRID:AB_528118
Rabbit anti-nerve growth factor (NGF-receptor), P75 1:1000 AB1554 EMD Millipore RRID:AB_90760
RRID:AB_90760
Anti-rabbit IgG MicroBeads 1:50 130-048-602 Miltenyi Biotec RRID:AB_244362
RRID:AB_244362
Alexa Fluors 594 Donkey anti-mouse 1:400 A21203 Molecular Probes (Invitrogen); RRID: AB_141633
RRID: AB_141633
Alexa Fluors 594 Donkey anti-rabbit 1:400 A21207 Life Technologies: RRID:AB_10049744
RRID:AB_10049744
Alexa Fluors 488 Donkey anti-rabbit 1:400 A21206 Life Technologies; RRID:AB_10049650
RRID:AB_10049650
Alexa Fluors 594 Donkey anti-goat 1:400 A11058 Life Technologies; RRID:AB_10563390
RRID:AB_10563390
Alexa Fluors 647 Donkey anti-rabbit 1:400 A31573 Life Technologies; RRID:AB_10561706
RRID¼Research Resource Identiﬁers (https://www.force11.org/node/4856).
a Covance was acquired by BioLegend in 2014 (new catalog # 802001; RRID not yet assigned)
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(PBD-GST) (Cytoskeleton, Denver) or 100 μg GST-tagged Rhotekin-
RBD protein (RBD-GST) (Cytoskeleton, Denver) (1 h, 4 °C) in 100 μl
TBST. Cells were PBS washed, post-ﬁxed (4% paraformaldehyde,
15 min, 25 °C), and washed again (PBS) before anti-GST
immunohistochemistry.
2.10. Microscopy and analysis
Micrographs were obtained with (1) Olympus BX60 or IX71,
Axiocam CCD, Axiovision software, (2) Olympus FV1000 confocal
with Fluoview software, (3) Zeiss Axio Imager.A2, AxioCam MRm
Rev.3, ZEN software, (4) Zeiss LSM 710 confocal, Zen software, (5)
Nikon Eclipse 80i, Spot camera, software version 3.3.1 (Diagnostic
Instruments). FIJI (NIH ImageJ) and Photoshop CS6 (Adobe) were
used to process images (Schindelin et al., 2012) including only
cropping, stitching (Preibisch et al., 2009), rotating, centering, and
uniform adjustments of brightness, contrast and saturation. Con-
focal images show ﬂattened Z-stacks. Time-lapse imaging used an
AxioObserver.Z1 microscope (Zeiss) with motorized stage and in-
cubator with temperature and CO2 controls. Live-imaging was at
37 °C and 5% CO2.
ENCDC colonization of mouse bowel was measured from cecal
tip to most distal TuJ1þ cell or neurite. For midgut slices, migra-
tion was measured in octants from slice edges to the most distal
ENCDC or mesenchymal cell (Supplemental Fig. 1). Octants ad-
jacent to other slices were not evaluated. ENCDC were RETþ by
immunohistochemistry. Mesenchymal cells were identiﬁed by
absent RET immunostaining and an actin-rich cytoskeleton after
Alexa488-phalloidin staining. Each slice was considered a single
replicate.
Lamellipodia were deﬁned as regions of obvious F-actin ruf-
ﬂing wider than the cell body and were analyzed in phalloidin-
stained ENCDC furthest from gut slices (Supplemental Fig. 1). The
longest neurites in RETþ cells were measured using FIJI (NIH
ImageJ). Cell speed was measured in time-lapse images using
MTrackJ manually (Meijering et al., 2012). Immunoﬂuorescent
pixel intensity was measured using FIJI on images taken at ﬁxedexposure times. Only RETþ cells that migrated furthest from
slices were analyzed for ﬂuorescence intensity. All samples for
which ﬂuorescence intensity was compared were stained on the
same chamber slide.
2.11. Statistical analysis
SigmaPlot 11 (Systat Software) and Excel (Microsoft) were used
for student's t-test or one-way ANOVA comparisons. All studies
include at least three biological replicates. Non-parametric data
were analyzed by ranks. Post-hoc Holm-Sidak or Dunn's tests were
used for multiple comparisons. Data are plotted as mean þ/
SEM unless noted. Po0.05 was considered signiﬁcant.
2.12. Approvals
All studies were approved by Animal Studies Committee at
Washington University School of Medicine, Institutional Animal
Care and Use Committee at The Children's Hospital of Philadelphia,
and by Massachusetts General Hospital's Institutional Sub-
committee on Research Animal Care.3. Results
3.1. Ibuprofen inhibited enteric nervous system development in
zebraﬁsh
Zebraﬁsh embryos were exposed to selected medicines that are
used by 40.5% of women during early pregnancy (Thorpe et al.,
2013) (Table 1). Fish were treated during the period that ENCDC
migrate through bowel (34–96 hpf (hours post fertilization)) and
then stained with Elavl3/4 (HuC/D) antibody to show enteric
neurons (Kuhlman and Eisen, 2007; Lake et al., 2013). Ibuprofen
and acetylsalicylic acid speciﬁcally reduced bowel colonization by
ENCDC at concentrations found in human blood with therapeutic
dosing (Table 1). We focused on ibuprofen because it inhibited
bowel colonization by ENCDC in a dose dependent manner
Fig. 1. Ibuprofen reduced ENCDC colonization of zebraﬁsh bowel. (A–D) Zebraﬁsh were treated with vehicle (1% DMSO) or ibuprofen (Ibu) from 34 to 96 hpf and then
stained with HuC/D antibody. (A) White arrows indicate dorsal root ganglia. (C) White arrows highlight enteric neurons. Scale bar¼500 μm. (B and D) Higher magniﬁcation
of ﬁsh midsection. Scale bar¼100 μm. (E) Length of bowel from most distal HuC/Dþ cell (arrows in B and D) to bowel terminus (arrowheads in B and D). *Po0.05 (ANOVA
on Ranks) (F) Length of whole zebraﬁsh (1% DMSO n¼4, 25 μM Ibuprofen n¼6). *P¼0.025 (t-test). (G) Distance between DRG and dorsal zebraﬁsh edge (1% DMSO n¼3,
25 μM ibuprofen n¼4). *P40.05 (t-test).
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660 μM (i.e., twice the dose that caused ENS defects) suggesting
more generalized toxicity. In contrast, at an ibuprofen dose that
reduced bowel colonization by ENCDC (25 μM), ﬁsh looked grossly
normal (Fig. 1A–D). Body length was slightly reduced (Fig. 1A, C,
and F), but dorsal root ganglia (DRG), another neural crest-deri-
vative, were in a normal position after ibuprofen treatment
(Fig. 1A, C, and G). Furthermore ﬁsh treated with 25 μM ibuprofen
had a normal number of DRG neurons per ganglion (DMSO 2.2
þ/ 0.09, ibuprofen 2.1 þ/ 0.1, p¼0.3, 2 tailed t-test). These
data suggest that ibuprofen inhibits zebraﬁsh bowel colonization
by ENCDC at concentrations that do not globally disrupt devel-
opment or block migration of other neural crest derivatives.
3.2. Ibuprofen inhibits ENCDC colonization of chick bowel in organ
culture
To determine if ibuprofen affects ENS development in other
species we cultured E6 chick hindgut for 48 h with or without
ibuprofen (250 μM) and then stained with N-cadherin antibody
(Fig. 2A and B). This ibuprofen concentration was selected based
on work in mouse culture (Fig. 3) where higher ibuprofen doses
are needed to affect ENCDC migration. This ibuprofen level is
comparable to human serum levels after consuming three over-
the-counter ibuprofen tablets (i.e., 600 mg, a commonly used
dose) (Ritschel and Kerns, 2009). Remarkably, ibuprofen-treated
hindgut was almost devoid of ENCDC, whereas control bowel was
almost fully colonized by ENCDC (n¼6 per treatment group).
Proliferation of ENCDC was also reduced by ibuprofen based onEdU incorporation into N-Cadherin expressing cells at the leading
edge of the migration wavefront (N-CadherinþEdUþ/N-
Cadherin100: Control 58 þ/ 0.06%, ibuprofen 38 þ/ 0.05%,
P¼0.03, n¼6/group, t-test) as was proliferation in gut mesench-
ymal cells (DAPIþN-Cadherin-EdUþ/DAPIþN-Cadherin-100:
Controls 20 þ/ 1.5%, ibuprofen 13 þ/ 0.9%, P¼0.03, n¼6/
group, t-test). Thus in chick and in ﬁsh, ibuprofen dramatically
reduced colon colonization by ENCDC. In chick, this was accom-
panied by reduced proliferation of ENCDC and surrounding me-
senchymal cells.
3.3. Ibuprofen slows ENCDC colonization of mouse bowel in vivo
To determine if ibuprofen affects mammalian ENCDC develop-
ment, we fed ibuprofen to two mouse lines with genetic defects
that predispose to HSCR-like disease. Pregnant mice with Ret or
Sox10 mutations received ibuprofen containing or control chow
from E8.5 to E12.5. We selected these dates because E8.5 is one
day before ENCDC enter fetal bowel and by E12.5 ENCDC have
normally migrated to mid-colon. We then stained the bowel with
an antibody to neuron speciﬁc β3 tubulin (TuJ1) (Fig. 2C–F). Ibu-
profen-exposed Retþ / mice had a small, but signiﬁcant reduc-
tion in bowel colonization by ENCDC (% colon colonization: un-
treated Ret þ/ 73.673.9%, n¼4; ibuprofen treated Retþ /
65.275.2% n¼9, Po0.042, t-test). In contrast, colon colonization
by ENCDC was normal in ibuprofen treated E12.5 Sox10þ / mice
and in E12.5WT littermates of Sox10þ / and Retþ / animals (%
colon colonization: untreated Sox10þ / 59.472.4% n¼19; ibu-
profen Sox10þ / 60.372.3% n¼13, p¼0.79, t-test and data not
Fig. 2. Ibuprofen inhibited hindgut colonization by chick ENCDC ex vivo and mouse ENCDC in vivo. (A, B) Ibuprofen (250 μM) almost completely blocked E6 chick colon
colonization by N-cadherinþ (green) ENCDC during 48 h culture. (Scale bar¼200 μM, n¼6 per group). Insets show the migration wavefront with EdU (red) and N-cadherin
(green) immunohistochemistry. (Scale bar¼35 μM for inset images). mg¼midgut, hg¼hindgut. (C–E) Ibuprofen feeding from E8.5 to E12.5 reduced Ret þ / mouse colon
colonization by ENCDC visualized with TuJ1 antibody (red). Scale bars¼400 μM. (E and F) Quantitative data show the proportion of the colon colonized by ENCDC (i.e., length
of colon containing ENCDC divided by total colon length) (Control n¼4, ibuprofen n¼9). *P¼0.042 (t-test). (F) Sox10 þ / colon was normally colonized by ENCDC when
dams were fed ibuprofen from E8.5 to E12.5 (Control n¼19, ibuprofen n¼13). P¼0.79 (t-test).
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can delay ENCDC colonization of fetal bowel in vivo, although the
effect is more subtle than in chick and ﬁsh.
3.4. Ibuprofen speciﬁcally inhibited murine ENCDC migration in vitro
To gain insight into why ibuprofen slowed bowel colonization
by ENCDC, we cultured E12.5 CF-1 mouse gut slices on ﬁbronectin
coated dishes in the presence or absence of ibuprofen (Fu et al.,
2013, 2010; Lake et al., 2013; Wang et al., 2010). Addition of GDNF
to the culture media enhanced ENCDC migration onto the dishes
permitting drug effects on ENCDC migration, proliferation, cell
death and differentiation to be evaluated. After 16 h in culture,
ENCDC were identiﬁed by RET immunoreactivity. RET is expressed
by all ENS precursors and differentiated enteric neurons in vitro
(Heuckeroth et al., 1998; Pachnis et al., 1993). ENCDC migration
was assessed by measuring the distance between gut slice edges
and the most distant ENCDC (Supplemental Fig. 1). 250 μM ibu-
profen reduced the distance ENCDC migrated from gut slices, but
migration distance was normal at lower ibuprofen concentrations
(50 μM, 100 μM) (Fig. 3A, B, and I).
Since ENCDC migration might be affected by the number of
migrating ENCDC and by differentiation (Lake et al., 2013), we
determined if ibuprofen altered ENCDC proliferation, apoptosis, or
differentiation. Double label immunohistochemistry for RET (ex-
pressed in ENCDC and enteric neurons) plus BrdU, RET plus acti-
vated caspase-3, and RET plus TuJ1 (neuron speciﬁc β3 tubulin
antibody that identiﬁes early neurons) demonstrated ibuprofen
had no effect on murine ENCDC proliferation, apoptosis, or dif-
ferentiation (Fig. 3C–H and J–L). These data suggest ibuprofen
speciﬁcally affects murine ENCDC migration without alteringsurvival, proliferation or differentiation.
3.5. NIH 3T3 and gut mesenchymal cell migration was not affected
by ibuprofen
To determine if ibuprofen affects migration of other cells, we
performed “scratch test migration assays” on conﬂuent NIH3T3
ﬁbroblasts. After two hours of ibuprofen treatment, we created a
wound to induce migration (Fig. 4A–D) and imaged for 24 h.
Ibuprofen did not slow NIH3T3 migration (P¼0.75) (Fig. 4A–E). To
determine if ibuprofen effects require specialized media or factors
produced by bowel, we examined CF-1 mesenchymal cells that
migrated from the gut along with ENCDC (Supplemental Fig. 1).
Like NIH3T3, gut mesenchymal cell migration was not affected by
ibuprofen (Fig. 4G). These data suggest that ENCDC migration is
especially sensitive to ibuprofen, compared to other cell types.
3.6. Ibuprofen-exposed ENCDC have reduced lamellipodia and ﬁla-
mentous actin
To assess if ibuprofen affected ENCDC morphology, we cultured
CF-1 mouse fetal bowel slices with or without ibuprofen for 16 h
and stained with phalloidin. Fewer ibuprofen treated migrating
ENCDC had lamellipodia than control ENCDC at all doses tested
(Fig. 5A–F, I). In contrast, ibuprofen did not reduce well-formed
lamellipodia in NIH 3T3 (Fig. 4F) nor in gut mesenchymal cells
(Fig. 4H). This ﬁnding may underlie ibuprofen effects on ENCDC
migration because lamellipodia are thin membranous projections
with dynamic networks of cross-linked actin ﬁlaments that facil-
itate cell migration (Hall, 2005).
Lamellipodia formation is driven by actin polymerization and
Fig. 3. Ibuprofen reduced murine ENCDC migration, but did not affect proliferation, caspase-3 activation, or neuronal differentiation. E12.5 CF-1 midgut slices cultured with
or without ibuprofen for 16 h after GDNF addition were stained for (A, B) RET (red), phalloidin (green), DAPI (blue) (scale bar¼200 μm), (C, D) RET (green), BrdU (red), DAPI
(blue) (Scale bar¼100 μm), (E, F) RET (red), cleaved-caspase 3 (green), DAPI (blue) (Scale bar¼100 μm), or (G, H) RET (green), TuJ1 (red), DAPI (blue) (scale bar¼100 μm).
(I) Ibuprofen reduced the distance ENCDC migrated from gut explants at 250 μM and 500 μM, but not at lower ibuprofen concentrations. Control n¼275 slices, 29 biological
replicates; 50 μM ibuprofen n¼48 slices, 3 biological replicates; 100 μM ibuprofen n¼55 slices, 3 biological replicates; 250 μM ibuprofen n¼111 slices, 5 biological replicates;
500 μM ibuprofen n¼102 slices, 8 biological replicates. **Po0.001 (ANOVA). (J) Mean percentage BrdUþ ENCDC (RETþ cells) (Control n¼21 slices, 7 biological replicates;
ibuprofen n¼9 slices, 3 biological replicates). P¼0.24 (t-test). (K) Mean percentage cleaved-caspase 3þ ENCDC (RETþ cells) (Control n¼15 slices, ibuprofen n¼15 slices;
both 3 biological replicates). P¼0.36 (t-test). (L) Mean percentage TuJ1þ ENCDC (RETþ cells) (Control n¼19 slices, ibuprofen n¼23 slices; both 3 biological replicates).
P¼0.35 (t-test).
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ﬂuorescence intensity of Alexa488-phalloidin stained ENCDC.
Ibuprofen treated ENCDC had reduced Alexa488 staining sug-
gesting that ibuprofen affects ENCDC actin dynamics (Fig. 5A–F, J
and K). As actin polymerization is also important for neurite
growth we assessed neurite length and found that ibuprofen re-
duced neurite length by 36% when dissociated ENCDC differentiate
in vitro (Fig. 5G–H and L). This contrasts with studies showing
ibuprofen enhanced neurite growth in corticospinal neurons,
dorsal root ganglion cells (Fu et al., 2007) and raphespinal neurons
(Wang et al., 2009) via PPARγ and reduced RHOA/ROCK signaling
(Dill et al., 2010). Developing enteric neurons, however, have much
less PPARγ than dorsal root ganglion neurons (Fig. 6) providing a
possible explanation for different ibuprofen effects. Collectively
these data suggest ibuprofen slows ENCDC migration and reduces
neurite length in ENCDC-derived neurons by altering actin cytos-
keletal dynamics.
3.7. Ibuprofen slows ENCDC migration but effects are delayed
To gain insight into the mechanism by which ibuprofen slows
ENCDC migration, we performed time-lapse microscopy on gut
slice cultures with ibuprofen added at the initiation of imaging
(Fig. 7 A–D, Supplemental Movies 1 and 2). Analysis of sequential
images showed that ENCDC persistence (net distance migrated/
total distance migrated) was unaffected by ibuprofen (data not
shown), but ENCDC migration speed was reduced. Interestingly,
the effect on migration speed was only apparent after 3 h of ibu-
profen (i.e., during “imaging interval 4”, Fig. 7A, E andSupplemental Movies 1 and 2). This is much longer than would be
expected if ibuprofen effects were mediated by COX inhibition, the
primary therapeutic effect of ibuprofen (Peppelenbosch et al.,
1993; Vane, 1971). One possible explanation for delayed ibuprofen
responsiveness of ENCDC is that prolonged contact with tissue
culture surfaces changes ENCDC biology so that these cells become
ibuprofen sensitive. To test this hypothesis, we added ibuprofen
just as gut slices were placed in culture (i.e. four hours before
initiation of imaging (Supplemental Movie 3)) and observed that
ibuprofen-mediated effects on ENCDC migration were already
apparent when imaging began. This suggests that the delayed
response of ENCDC to ibuprofen was not dependent on a change in
ENCDC phenotype after migration onto the culture dish, but in-
stead is consistent with the hypothesis that ibuprofen effects on
ENCDC migration were COX-independent.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.09.023
3.8. Ptgs1  / Ptgs2  / mice have normal appearing ENCDC
migration in vitro and in vivo
To directly test if reduced COX activity affected ENCDC, we
cultured mid-small bowel slices from E12.5 Ptgs1 / Ptgs2 /
(i.e., Cox1 / Cox2 /) mice on ﬁbronectin and found no dif-
ference in ENCDC migration or lamellipodia compared to WT
(Fig. 8A, B, E, and F). We also stainedWT and Ptgs1  / Ptgs2  /
E12.5 bowel with TuJ1 antibody and found equivalent colon co-
lonization by ENCDC (Fig. 8C, D, and G). Finally, we tried to rescue
ibuprofen effects on CF-1 ENCDC using stable analogs of two
Fig. 4. Ibuprofen did not affect migration or lamellipodia of NIH 3T3 or mouse gut mesenchymal cells. Conﬂuent NIH 3T3 were pretreated with 250 μM ibuprofen (2 h)
before making a scratch to remove some cells. (A and B) NIH3T3 immediately after the scratch was made. (C and D) Two hours after the scratch. Scale bar = 200 μm. Cells
were imaged every 5 min for 24 h. 250 μM ibuprofen did not affect (E) average speed of gap closure (Control n¼5 assays, ibuprofen; n¼7 assays), P¼0.76 (t-test) or
(F) percentage of NIH 3T3 with lamellipodia (Control n¼8 assays, ibuprofen; n¼9 assays). P¼0.75 (t-test). (G and H) 250 μM ibuprofen did not affect distance CF-1
mesenchymal cells migrated from gut explants (Control n¼19 slices, ibuprofen n¼24 slices; 3 biological replicates). P¼0.57 (t-test) or the percentage of mesenchymal cells
with lamellipodia after 16 h (Control¼9 slices, ibuprofen¼9 slices; 3 biological replicates). P¼0.52 (t-test).
E.M. Schill et al. / Developmental Biology 409 (2016) 473–488480prostaglandins (PGE2 and PGF2) reported to facilitate cell migra-
tion (16,16-dimethyl PGE2 or 16, 16-dimethyl PGF2 respectively),
but did not observe any effect on migration or lamellipodia
(Fig. 8H–K). These data also suggest that ibuprofen effects on
ENCDC migration may be COX-independent.
One caveat is that Ptgs mutant animals were on a C57BL/6 ge-
netic background. We therefore cultured E12.5 small bowel slices
from C57BL/6 mice on ﬁbronectin in media with GDNF þ/ ibu-
profen. Ibuprofen did not reduce ENCDC migration from WT
C57BL/6 gut (Distance of most distant ENCDC from gut slice: WT335 þ/ 7 μM; 250 μM ibuprofen 343 þ/ 7 μM, 4 biological
replicates, 128 control slices, 161 ibuprofen slices, P¼0.39, t-test),
however, when this experiment was performed using C57BL/6
Retþ / gut explants, ENCDC migration was reduced by ibuprofen
(untreated: 349 þ/ 7 μM, 250 μM ibuprofen 324 þ/ 7 μM,
4 biological replicates 125 control slices, 147 ibuprofen slices,
P¼0.015, t-test), consistent with our in vivo results. These data
suggest that the C57BL/6 genetic background makes ENCDC more
resistant to ibuprofen effects on migration compared to CF-1.
Fig. 5. Ibuprofen reduced lamellipodia in migrating murine ENCDC and reduced neurite length in differentiating murine enteric neurons. (A–F) E12.5 CF-1 midgut slices
were cultured with 250 μM ibuprofen or control media for 16 h after GDNF addition and then stained for (A and D) RET, (B and E) Alexa488-phalloidin, and (C and F) DAPI
(merged image). Arrows highlight well-formed lamellipodia. (G and H) Dissociated immunoselected E12.5 CF-1 ENCDC cultured 48 h were stained for RET (red), TuJ1 (green)
and DAPI (blue). Scale bars¼50 μM. (I and J). (I) The percentage of migrating ENCDC with lamellipodia was reduced by 50 μM or higher ibuprofen concentrations. RETþ
ENCDC most distant from the gut slices were analyzed. (Control n¼61 slices, 13 biological replicates; 50 μM Ibuprofen n¼9 slices, 3 biological replicates; 100 μM ibuprofen
n¼9 slices, 3 biological replicates, 250 μM ibuprofen n¼27 slices, 9 biological replicates; 500 μM ibuprofen n¼12 slices, 4 biological replicates). *Po0.05, **Po0.001,
(ANOVA, Holm-Sidak method). (J,K) Ibuprofen reduced mean Alexa488-phalloidin ﬂuorescence intensity for RETþ ENCDC on a per pixel basis (J) as well as per cell (K)
(Control n¼232 cells, ibuprofen n¼236 cells; both 4 biological replicates). *Po0.001 (Mann–Whitney Rank Sum). (L) Ibuprofen reduced longest neurite in cultured dif-
ferentiating ENCDC (Control n¼50, ibuprofen n¼76, both 3 biological replicates). *P¼0.009 (Mann–Whitney Rank Sum).
Fig. 6. E12.5 CF-1 mouse ENCDC had less immunoreactive PPARγ than E12.5 dorsal root ganglion (DRG) neurons. Sagittal sections were stained with antibodies to PPARγ
(red) and neuron speciﬁc beta 3 tubulin (green, TuJ1). (A–D) PPARγ is readily detectable in DRG neurons. The boxed region in C contains DRG neurons that are im-
munoreactive for both PPARγ and TuJ1 antibodies (yellow cells) and is enlarged in D to show DRG neurons immunoreactive for PPARγ staining (red cells, white arrows). (E–H)
Developing enteric neurons (TuJ1þ cells highlighted with arrows in F) have much lower levels of immunoreactive PPARγ (i.e., no yellow cells in the region of the ENS in G).
The boxed region in G is enlarged in H to show the lack of PPARγ staining (red) in the ENCDC. Arrows highlight the region of the developing ENS. Images are from the same
fetal mouse stained on the same slide. Scale bar¼100 μm.
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Fig. 7. Ibuprofen had delayed effects on murine ENCDC migration. (A) Experimental paradigms. E12.5 CF-1 midgut slices were cultured on ﬁbronectin. Ibuprofen was added
four hours after plating (termed ibuprofen late) or at plating (termed ibuprofen). Time lapse images were then obtained every two minutes for four hours. (B–D) DIC images
show ﬁnal time points from time-lapse movies. Tracks show trajectories for single cells that migrated from explants. Immunohistochemistry after imaging conﬁrmed tracked
cells expressed RET. Scale bar¼100 μm. (E) Mean ENCDC migration speed during each one hour interval. Ibuprofen slowed ENCDC speed, but not until 3–4 h after ibuprofen
exposure (Control n¼130 cells, Ibuprofen n¼180 cells, ibuprofen late n¼92 cells; all 3 biological replicates). *Po0.05 (ANOVA on ranks).
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Reduced F-actin, lamellipodia, and neurite growth in ibuprofen
treated ENCDC suggested reduced RAC1 or increased RHOA ac-
tivity (Bryan et al., 2005; Hall, 2005; Koh, 2006; Sato and Heuck-
eroth, 2008; Wang et al., 2003). We attempted to measure active
RAC1 and RHOA in migrating ENCDC using sensitive G-LISA kits
(Ferri et al., 2014; Nini and Dagnino, 2010), but could not obtain
reproducible results. Furthermore, we wanted to measure RAC1
and RHOA activity only in cells that migrated furthest from cul-
tured gut slices (i.e., distal ENCDC, Supplemental Fig. 1) because
these cells were examined for all other studies. Therefore we used
a validated “in situ” method to analyze active RAC1/CDC42 or ac-
tive RHOA based on binding to p21 PAK binding domain (PBD) or
rhotekin binding domain (RBD) respectively, fused to glutathione-
S-transferase (GST) (Supplemental Fig. 2) (Li et al., 2002; Lindsley
et al., 2011). Gut slices were cultured with or without ibuprofen,ﬁxed and incubated with PBD-GST or RBD-GST followed by GST
immunohistochemistry. Analysis of mean ﬂuorescence intensity in
ENCDC that migrated furthest from the gut edge demonstrated
less PDB-GST immunoreactive protein in ibuprofen-treated
ENCDC, suggesting less active RAC1/CDC42 than in control ENCDC
(Fig. 9A–H, Supplemental Fig. 2A and C). In contrast, active RHOA
levels were similar in ibuprofen-treated and control ENCDC based
on RBD-GST binding (Fig. 9I–P, Supplemental Fig. 2B and D). Col-
lectively these data suggest ibuprofen hinders ENCDC migration by
reducing active RAC1 without affecting RHOA activity.
3.10. ROCK inhibition rescues ibuprofen effects on ENCDC migration
in vitro
RAC1 and RHOA are regulated in complex ways as they control
actin cytoskeleton to alter cell morphology (Guilluy et al., 2011;
Hall, 2005; Parri and Chiarugi, 2010). We hypothesized that if
Fig. 8. Ibuprofen effects on murine ENCDC migration and lamellipodia do not appear to be cyclooxygenase dependent. Ptgs1 / Ptgs2 / mice have normal ENCDC
migration in vitro and normal bowel colonization in vivo. (A, B) E12.5 WT C57BL/6 and Ptgs1 / Ptgs2 / midgut slices were cultured 16 h after GDNF addition and then
stained with RET antibody (red), phalloidin (green), and DAPI (blue). Scale bar¼50 μM. (C, D) E12.5 bowel from WT and Ptgs1 / Ptgs2 / mice was stained with Tuj1
antibody. Scale bar¼500 μM. Ptgs1-/- Ptgs2-/-mutations did not affect (E) the mean distance that ENCDC migrated from gut slices (WT n¼57 slices, 5 embryos and Ptgs1 /
Ptgs2 / n ¼48, slices, 7 embryos), P¼0.55 (t-test), or (F) the mean percentage of ENCDC with a well-formed lamellipodia (WT n¼11 slices, 4 embryos and Ptgs1 /
Ptgs2 / n ¼10 slices, 5 embryos), P¼0.38 (t-test), or (G) the extent of bowel colonization by ENCDC in vivo (WT n¼6 and Ptgs1 / Ptgs2 / n ¼5), P¼0.23 (t-test). Only
ENCDC most distant from gut slices were evaluated for lamellipodia. (H–K) Stable Prostaglandin E2 (PGE2) and Prostaglandin F2 (PGF2) analogs did not rescue ibuprofen-
induced ENCDC migration defects. E12.5 CF-1 midgut slices were cultured in media with GDNF with or without ibuprofen for 16 h and then stained for RET, F-actin
(phalloidin) and with DAPI. (H, I) Distance from the gut slice edge to the most distant RETþ ENCDC was measured. Neither 16, 16-dimethyl PGE2 (H) nor 16, 16-dimethyl
PGF2 (I) restored ENCDC migration to control levels in the presence of ibuprofen, but 16,16-dimethyl PGE2 (H) did reduce ENCDC migration in the absence of ibuprofen. (For
PGE2 studies: Control n¼165 slices, ibuprofen n¼112 slices, 16, 16-dimethyl PGE2 n¼137 slices, ibuprofen plus 16, 16-dimethyl PGE2 n¼53 slices; *Po0.05 compared to
Control. #Po0.05 compared to Prostaglandin E2 (ANOVA). For PGF2 studies: Control n¼103 slices, ibuprofen n¼96 slices, 16, 16-dimethyl PGF2 n¼127 slices, ibuprofen plus
PGF2 n¼107 slices; *Po0.05 compared to Control. #Po0.05 compared to Prostaglandin F2 (ANOVA on Ranks)) (J, K) The percentage of ENCDC with well-formed la-
mellipodia was determined by examining phalloidin stained ENCDC that had migrated furthest from the gut slice edge. Neither 16, 16-dimethyl PGE2 nor 16, 16-dimethyl
PGF2 rescued lamellipodia in the presence of ibuprofen (For PGE2 studies: Control n¼27 slices, ibuprofen n¼18 slices, PGE2 n¼27 slices, ibuprofen plus PGE2 n¼18 slices)
*Po0.05 compared to Control. #Po0.05 compared to Prostaglandin E2 (ANOVA on Ranks). For PGF2 studies: Control n¼105 slices, ibuprofen n¼83 slices, 16, 16-dimethyl
PGF2 n¼105 slices, ibuprofen plus 16, 16-dimethyl PGF2 n¼93 slices *Po0.05 compared to Control. #Po0.05 compared to Prostaglandin F2 (ANOVA).
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reduced RAC1 activation, it might be possible to rescue ibuprofen's
effects by inhibiting ROCK, a RHOA effector kinase that inhibits
RAC1. To test this hypothesis, CF-1 midgut slices were cultured
with the ROCK inhibitor Y-27632 (Fig. 10). This drug increased
migration of ibuprofen-treated ENCDC to the level seen in control
cells, but did not affect ENCDC migration in the absence of ibu-
profen (Fig. 10M). These data suggest that excess RHOA/ROCK ac-
tivity relative to RAC1/CDC42 may underlie ibuprofen's effect on
ENCDC migration (Fig. 11).4. Discussion
Despite surgical treatment available for Hirschsprung disease
since 1948 (Swenson and Bill, 1948), approximately 5% of children
with HSCR die at an early age (Rescorla et al., 1992; Suita et al.,
2005) and 440% have problems after surgery (El-Sawaf et al.,
2013; Menezes et al., 2008). It would therefore be ideal if HSCR
could be prevented from occurring in the ﬁrst place. We now
believe this may be possible in some cases by optimizing maternal
nutrition, health, and medication use before conception and dur-
ing early pregnancy. If non-genetic risk factors were identiﬁed,
targeted advice could be provided to families at “high genetic risk”
for HSCR. From this standpoint it is particularly valuable to identify
common and avoidable exposures.
Using zebraﬁsh to test medicines commonly used by pregnant
women we discovered that ibuprofen causes HSCR-like absence of
neurons in developing ﬁsh bowel in vivo. Studies in mice also show
ibuprofen can slow colonization of fetal bowel in vivo. Most dra-
matically, ibuprofen treatment of fetal chick bowel led to almost
complete absence of colon colonization by ENCDC. Detailed ana-
lysis of actively migrating mouse ENCDC conﬁrmed ibuprofen
slowed migration, reduced lamellipodia, reduced ﬁlamentous ac-
tin, and reduced RAC1 activation. These in vitro and in vivo data
suggest ibuprofen use during the period that ENCDC colonize fetal
bowel (e.g. week 3–8 of human gestation) might increase HSCR
risk.
Human studies are now needed to extend this work. Although
ibuprofen reduced ENCDC colonization of fetal bowel in three
species, the dose needed and severity of inhibitory effects differed
between species. The reason for interspecies and interstrain dif-
ferences is not known, but may reﬂect differences in drug meta-
bolism, the presence of alternative migration modes, target sen-
sitivity, or intracellular signaling. One valuable approach will be
human HSCR epidemiologic studies examining maternal medica-
tion use in early pregnancy.
To put the mouse in vivo studies in context, Retþ / mice fed
375 ppm ibuprofen in chow had a 12% reduction in ENCDC colo-
nization of colon at E12.5. This dose was selected because it sup-
presses COX-dependent inﬂammation (Lim et al., 2000; Ritschel
and Kerns, 2009) and gives serum levels (60–70 μM) (Morihara
et al., 2005) within the human therapeutic dosing range (RitschelFig. 9. Ibuprofen reduced active RAC1/CDC42, but did not affect active RHOA in migrat
permeabilized and incubated with (A–H) PBD-GST that binds active GTP-RAC1 and GT
stained for (A, D, I, L) RET (green), (B, E, J, M) GST (red), and (C, F, K, N) DAPI (blue; merge
RBD-GST (O) for ENCDC that migrated furthest from gut slices. (G) 250 μM Ibuprofen trea
n¼243 cells, ibuprofen n¼205 cells, both 4 biological replicates); *Po0.001 (Mann–Wh
actively migrating ENCDC (Control n¼144 cells, ibuprofen n¼136 cells, both 4 biologica
altered by ibuprofen and this may change mean ﬂuorescence intensity per pixel, total ﬂu
for (H) active RAC1/CDC42 (via PGD-GST binding) (Control n¼243 cells, ibuprofen n¼2
(Control n¼144 cells, ibuprofen n¼136 cells, both 4 biological replicates) per cell. *Po
cellular levels of F-actin and active RAC1/CDC42 without affecting active RHOA levels. Oand Kerns, 2009). Because ibuprofen use in early pregnancy is
common (almost 1 in 4) (Thorpe et al., 2013) and HSCR relatively
rare (about 1:5000) (Amiel et al., 2008), ibuprofen alone is un-
likely to cause HSCR in humans even at higher doses. Ibuprofen
might, however, increase HSCR occurrence in the context of un-
derlying genetic risk. This is important because known genetic
causes for HSCR are partially penetrant suggesting gene–gene or
gene–environment interactions cause HSCR. This was demon-
strated dramatically in mice by the observation that Retþ / mice
never have distal bowel aganglionosis (McCallion et al., 2003), but
develop HSCR-like disease more readily than WT when other
mutations or non-genetic risk factors are present (Arnold et al.,
2009; Carrasquillo et al., 2002; Fu et al., 2010; Gunadi et al., 2014;
Lake et al., 2013; McCallion et al., 2003; Phusantisampan et al.,
2012; Wallace and Anderson, 2011). In contrast to mice, humans
with a single inactive RET allele (i.e., 30% of HSCR cases) have
about a 50% chance of having HSCR (Amiel et al., 2008). The vast
majority of these children have only a small region of distal
aganglionic bowel, suggesting that even small changes in bowel
colonization efﬁciency by ENCDC could have an important effect
on HSCR occurrence. For example, in mice, male sex only slightly
reduces bowel colonization by ENCDC similar to the effect of
ibuprofen (Vohra et al., 2007b), but in humans the male sex in-
creases HSCR occurrence four-fold.
From the standpoint of human teratogenicity, it may be im-
portant that ibuprofen effects on ENCDC appear likely to be COX-
independent. COX (PTGS) enzymes that make prostaglandins
(Vane, 1971) are the primary therapeutic target of ibuprofen and
other NSAIDs, but Ptgs1/ Ptgs2 / mice had normal bowel
colonization by ENCDC and normal ENCDC migration in vitro.
Furthermore, prolonged ibuprofen exposure and high doses were
needed to slow migration. NSAIDs should inhibit COX enzymes
much faster (with effects apparent within 10 minutes) and at low
micromolar doses (IC50¼2.1 μM for PTGS1 and 1.6 μM for PTGS2)
(Peppelenbosch et al., 1993; Tegeder et al., 2001). One caveat is
that our Ptgs mutant mice were C57BL/6 genetic background,
which appears more resistant to ibuprofen effects than CF-1.
The precise mechanisms through which ibuprofen inhibits ENCDC
migration remain uncertain, but our observations suggest ibuprofen
treated ENCDC have abnormal regulation of actin dynamics. Reduced
neurite growth in ibuprofen treated ENCDC was not anticipated since
ibuprofen increased neurite growth in several other neuron types (Fu
et al., 2007; Wang et al., 2009). We hypothesize this cell-type speciﬁc
difference occurs because unlike other neurons tested, ENCDC have
low levels of PPARγ that is required for ibuprofen to reduce RHOA
activity and enhance neurite growth (Dill et al., 2010). The lack of
ibuprofen effect on NIH 3T3 or CF-1 gut mesenchymal cell migration
and lamellipodia further highlights how cell-type speciﬁc gene ex-
pression impacts biology and emphasizes that extrapolation from one
cell type to another may be misleading.
Our studies suggest ibuprofen reduces active RAC1/CDC42 in
migrating ENCDC. This ﬁts with emerging literature on the role of
small RhoGTPases in neural crest-derived cell migration. Eleganting murine ENCDC. E12.5 CF-1 midgut slices cultured 16 h with GDNF were ﬁxed,
P-CDC42, or (I–P) with RBD-GST that binds active GTP-RHOA. Cultures were then
d image). Scale bar¼50 μm. (G, O) Mean ﬂuorescence intensity for PBD-GST (G) and
ted ENCDC had less bound PBD-GST indicating reduced active RAC1/CDC42 (Control
itney Rank Sum), but did not have reduced (O) RBD-GST bound to active RHOA in
l replicates). P¼0.408 (Mann–Whitney Rank Sum). (H, P) Because ENCDC shape is
orescence intensity (mean ﬂuorescence intensity/pixelpixels/cell) was determine
05 cells, both 4 biological replicates), and (P) active RHOA (via RBD-GST binding)
0.001, Mann–Whitney Rank Sum. These data indicate that ibuprofen reduced total
nly ENCDC furthest from the gut slice edge were analyzed.
Fig. 10. ROCK inhibition rescued ibuprofen effects on murine ENCDC migration. (A-L) E12.5 CF-1 midgut slices were cultured with or without 250 μM ibuprofen four hours
before GDNF and 5 μM Y-27632 were added. Sixteen hours later cultures were ﬁxed and stained for (A, D, G, J) RET (red), (B, E, H, K) phalloidin (green), and (C, F, I, L) DAPI
(blue; merged image). Scale bar¼50 μM. (M) Distance from the gut slice edge to the most distant RETþ ENCDC was measured. Y-27632 increased migration of ibuprofen
treated ENCDC, but not control ENCDC (Control n¼43 slices, ibuprofen n¼48 slices, Y-27632 n¼54 slices, ibuprofenþY-27632 n¼59 slices, all from 7 biological replicates).
*Po0.05 compared to control, #Po0.05 compared to ibuprofenþY-27632 (ANOVA on ranks).
E.M. Schill et al. / Developmental Biology 409 (2016) 473–488486in vivo FRET studies showed RAC1 promotes ENCDC chain migra-
tion through fetal bowel (Goto et al., 2013). Reduced RAC1 activity
in ibuprofen treated ENCDC provides a reasonable explanation for
reduced migration and fewer lamellipodia. The ability of ROCK
inhibition to prevent ibuprofen induced changes in migration and
lamellipodia, without any apparent alteration of RHOA activity,
may occur because RAC1 and RHOA usually inhibit each other andROCK is a RHOA effector kinase (Fig. 9) (Nakayama et al., 2008;
Sordella and Van Aelst, 2008).
5. Conclusions
These data demonstrate that ibuprofen, a medication com-
monly used in the ﬁrst trimester of pregnancy, inhibits ENCDC
Fig. 11. Model. RAC1 organizes the actin cytoskeleton to form lamellipodia and
support migration. Ibuprofen reduced ENCDC RAC1 activation. ROCK is a RHOA
effector that inhibits RAC1. Y-27632 inhibits ROCK to permit RAC1 activation, en-
hancing ENCDC migration.
E.M. Schill et al. / Developmental Biology 409 (2016) 473–488 487migration and might increase HSCR risk in genetically susceptible
individuals. This study extends our previous observations de-
monstrating environmental risk factors like vitamin A deﬁciency
(Fu et al., 2010) and mycophenolate (Lake et al., 2013) can cause
HSCR-like disease in mice, especially when combined with pre-
disposing genetic changes. Human epidemiological studies are
necessary to determine the extent to which ibuprofen contributes
to HSCR risk.Conﬂict of Interest
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